Homepage  /  News

Post Graduate Diploma in Clinical Embryology- July 2015

Department of Reproductive Medicine, Chettinad Health City.


28 March 2015

| | | |


(Deemed to be University Under Section 3 of the UGC Act 1956)

Rajiv Gandhi Salai, Kelambakkam, Kancheepuram Dist., Tamil Nadu-603103, India



Post Graduate Diploma in Clinical Embryology

Applications are invited from suitably qualified candidates for the programme commencing in July 2015.


To train medical /dental graduates in all aspects of Assisted Reproductive Technology (ART)

and in the ethical practice of Assisted Reproductive Technology.


Eligibility: MBBS, BDS

Course Duration: One year full time taught program  


Course Details:   

*Curriculum includes two semesters

*One thesis presentation

*Five journal club presentations

*Full hands on training in Andrological procedures like

*Semen analysis, Sperm preparation for IUI, ART, Surgically retrieved spermatozoa and Semen freezing techniques.

*Observation in human ART programs

*Full hands on training in Assisted Reproductive Technologies like IVF, ICSI , Blastocyst culture, freezing of gametes and embryos in animal models.    

*Five assignments.

Faculty: Internationally renowned faculty

All previous batch students have been successfully placed 

Contact person :  

Dr.D.Ramesh Raja, Clinical Embryologist,

Ms.Prathima , Embryologist

Dr.Asha Benziger, Junior Embryologist,

Dr.Ranjani , Junior Embryologist.

Contact no           :  044 47428300,8302,8305,8314

Website               :  www.chettinadhealthcity.com        

Contact Email id :                         

,                                                         ,



Share IVF News on FaceBook   Share IVF News on Google+   Share IVF News on Twitter

Page Views: 2783
Add to Favorites | Reply to Ad | Tell Your Friends
Date Added: 28 March 2015   Date Updated: 28 March 2015
Customer Reviews (0)
write a review
(No reviews found. You may write the first one!)

Join Our Newsletter - Don't Miss Anything!!!

Stay in touch with the latest news by subscribing to our regular email newsletters